Navigating the Evolving Treatment Landscape in HER2-mutated NSCLC - Episode 5
Experts on HER2-mutated NSCLC discuss the patient populations in which they’d utilize trastuzumab deruxtecan and share their clinical experiences with the therapy.
Related Content: